Gastrointestinal bleeding (GIB) is a common medical emergency that healthcare professionals encounter. Understanding its complex pathophysiology and mastering its clinical approach are pivotal in improving patient outcomes.
Upper GIB is most commonly due to peptic ulcer disease, followed by esophageal varices and gastritis. Lower GIB, on the other hand, is often caused by diverticulosis, angiodysplasia, and colorectal neoplasms. The pathophysiology of GIB involves the disruption of the mucosal barrier, leading to exposure of subepithelial blood vessels to gastric acid and pepsin.
Patients with GIB often present with hematemesis, melena, or hematochezia. However, the clinical presentation may vary, and some patients may present with non-specific symptoms such as fatigue, dizziness, or syncope.
The diagnostic approach to GIB involves both clinical assessment and investigations. Clinical assessment includes a thorough history and physical examination, while investigations may involve laboratory tests, endoscopy, and imaging studies.
Management of GIB involves resuscitation, risk stratification, and definitive treatment. Resuscitation includes fluid resuscitation and blood transfusion if necessary. Risk stratification helps to determine the need for hospital admission and the urgency of endoscopy. Definitive treatment depends on the cause of the bleed and may involve pharmacological therapy, endoscopic therapy, or surgery.
Mastering the clinical approach to GIB is crucial for healthcare professionals. This involves understanding the etiology and pathophysiology, recognizing the clinical presentation, knowing the diagnostic approach, and being familiar with the principles of management. With this knowledge, healthcare professionals can provide optimal care for patients with GIB and improve patient outcomes.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation